Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Joia Mukherjee

Global Health · Harvard Medical School

View

Dr. Jim Yong Kim

Global Health · Global Infrastructure Partners

View

Dr. Justin Hovey, FAAP, FACP, DABOM

Obesity Medicine · Noland Hospital Dothan II

View

Dr. Kimberly Gudzune

Obesity Medicine · JHU

View

Dr. Rebecca Andrews

Primary Care · UCHC

View

Dr. David Bates

General Internal Medicine · BWH

View

Dr. Reema Dbouk

Obesity Medicine · Emory University

View

Dr. Jennifer Paisley

Obesity Medicine · St. Elizabeth Medical Center

View

Dr. Molly Heublein

Primary Care · Clear Medical Clinic

View

Dr. Ryan Mire

Primary Care · Heritage Medical Associates

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    RC

    Dr. Rosa Coppolecchia

    Internal Medicine · Global Health
    Hackensack University Medical Center
    rosa

    Research

    Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use: A Subgroup Analysis of the OCEANIC-AF Randomized Clinical Trial

    2025

    Via JAMA Cardiology

    Research

    Bleeding Outcomes in Patients Treated With Asundexian in Phase II Trials

    2024

    Via Journal of the American College of Cardiology

    Research

    Bleeding Risk Prediction in Patients Treated with Antithrombotic Drugs According to the Anatomic Site of Bleeding, Indication for Treatment, and Time Since Treatment Initiation

    2024

    Via TH Open: Companion Journal to Thrombosis and Haemostasis

    Research

    An update on the taxonomy and functional properties of the probiotic Enterococcus faecium SF68

    2024

    Via Beneficial Microbes

    Research

    Corrigendum: Bleeding Risk Prediction in Patients Treated with Antithrombotic Drugs According to the Anatomic Site of Bleeding, Indication for Treatment, and Time Since Treatment Initiation

    2024

    Via TH Open: Companion Journal to Thrombosis and Haemostasis

    Research

    Participant Engagement and Preference Study for Clinical Outcomes Associated With Atrial Fibrillation: The PEARL-AF Study

    2024

    Via JACC. Advances

    Research

    Dietary Supplementation with the Probiotic SF68 Reinforces Intestinal Epithelial Barrier in Obese Mice by Improving Butyrate Bioavailability

    2023

    Via Molecular Nutrition & Food Research

    Research

    A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

    2022

    Via Circulation

    Research

    Enterococcus faecium SF68 as a model for efficacy and safety evaluation of pharmaceutical probiotics

    2018

    Via Beneficial Microbes

    Research

    Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial

    2018

    Via Lancet

    Research

    Budget Impact of Appropriate Low-Dose Aspirin Use for Primary and Secondary Cardiovascular Event Prevention in the Managed Care Setting

    2018

    Via Journal of Managed Care & Specialty Pharmacy

    Research

    An efficient thermostable organophosphate hydrolase and its application in pesticide decontamination

    2015

    Via Biotechnology and Bioengineering

    Research

    Antiplatelet effects of aspirin with phytosterols: comparison with non-enteric coated aspirin alone

    2009

    Via Thrombosis Research

    Research

    The translation initiation factor eIF4A from Schizosaccharomyces pombe is closely related to its mammalian counterpart

    1996

    Via Yeast

    Research

    A new yeast translation initiation factor suppresses a mutation in the eIF-4A RNA helicase

    1993

    Via The EMBO Journal